Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Explore clinical trials studying Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma trial results

Recruiting

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

NCT05370430

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Stanford, California, United States
  • University of Kansas Hospital Kansas City, Kansas, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

MB-CART20.1 Lymphoma

NCT03664635

Conditions
B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
Locations
  • University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany
  • Universitätsklikum Leipzig, AöR Leipzig, Germany
View Trial Details
Completed

Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation

NCT03456726

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • 1004 Eisai Trial Site Nagoya, Aichi-ken, Japan
  • 1029 Eisai Trial Site Nagoya, Aichi-ken, Japan
  • 1020 Eisai Trial Site Ōta, Gunma, Japan
  • 1007 Eisai Trial Site Sapporo, Hokkaido, Japan
View all 28 locations
View Trial Details

Related conditions